Drug Development

Drug Development
Medical Drugs
Trade Of The Day

Top Medical Drug Stock To Buy Now

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its […]

Read More
Biopharmaceuticals
Drug Development
Pharmaceuticals
Value Investing
Value Stocks

BMY is down big – does that make it a good bargain?

Over the course of my investing career, I’ve learned to rely on a lot of fundamental data to describe the underlying strength of any stock I might consider using for a value-based investment.  I’ve also learned to go beyond easy-to-reference, quick-glance data like earnings per share and price-to-earnings ratios, and to expand my view of […]

Read More
Drug Development
Medical Drugs
Trade Of The Day

Top Medical Drug Stock To Buy Now

CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. CBAY $8.5900 0.4900 % 6.0500 Cymabay Therapeutics Sector : Medical Industry : Medical – Generic Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 6.05% Wk: 6.84% Mo: 0.7% Yrly: 164.31% YTD: […]

Read More
Biopharmaceuticals
Biotechnology
Drug Development
Value Investing
Value Stocks

GILD is down more than -16.5% since the end of 2021. Is it a good buy yet?

No matter how tired we get of hearing about COVID-19, there is no denying that ever since the virus found its way to American shores, a lot of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world worked nonstop […]

Read More
Biopharmaceuticals
Biotechnology
Drug Development
Value Investing
Value Stocks

BMY’s short-term trend has the stock nearing its yearly high – how much room is left?

Over the course of my investing career, I have learned to rely on a lot of fundamental data to paint a picture about the underlying strength of any stock I might consider using for a value-based investment. While some fundamental investors prefer to work with easy-to-reference, quick-glance data like earnings per share and price-to-earnings ratios, […]

Read More
Biological Drug Manufacturing
Biopharmaceuticals
Biotechnology
Cancer
Cancer Biopharmaceuticals
Cash
Coronavirus
COVID-19
COVID-19 Pill
Defensive Stocks
Dividend Stocks
Dividend Yields
Dividends
Drug Development
Fibonacci Retracement
Free Cash Flow
Fundamental Analysis
Fundamentals
Oncology
Pharmaceuticals
Technical Analysis
Valuations
Value Investing
Value Stocks

MRK is up about 14% from its December low. Is it a good time to buy?

As I’ve studied the market over the years, one of the intriguing contrasts comes in the way different analysis methods take in the “big picture” of the market. That includes the way that fundamental investors and analysts look at the market versus those that prefer to work on strictly technical terms. I like to work […]

Read More
Clinical Laboratory
Drug Development
One Hot Stock

Laboratory Corporation of America Holdings (LH) – Buy Price: $309.00 or better

Buy Price: $309.00 or better Sell Price: TradersPro Sell Signal Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C […]

Read More